Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer Congress 2023

Selecting biomarkers to inform neoadjuvant strategies

Points to consider in the development of biomarkers in the neoadjuvant setting: Regulatory perspectives

Date

11 May 2023

Session

Selecting biomarkers to inform neoadjuvant strategies

Topics

Tumour Site

Breast Cancer

Presenters

Jonas Bergh

Authors

J. Bergh

Author affiliations

  • Karolinska Institutet - Bioclinicum, Solna/SE

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.